Sanofi SA Vaccines Investor Event Transcript - Thomson StreetEvents

Sanofi SA Vaccines Investor Event Transcript

Sanofi SA Vaccines Investor Event Transcript - Thomson StreetEvents
Sanofi SA Vaccines Investor Event Transcript
Published Jun 29, 2023
44 pages (32328 words) — Published Jun 29, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of SASY.PA corporate analyst meeting

  
Brief Excerpt:

...All right. Okay. Wow. Yes, it's really lovely to see such a crowded room. And if I could ask all of you, if you could just try to really put all your luggage a little bit under the chair or something. We just want to make sure that we have aisle free. All right. Good morning, good afternoon and good evening to everyone. Welcome to the Sanofi Vaccines Investor Event, streaming live from London. Thank you for joining us and spending the next 3 hours with us to discuss our Vaccines business. We have divided the event in 2 parts and have planned for a 20-minute break in between. If you're following us online, you can remain connected to the same Zoom link for both sessions....

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Sanofi SA
Ticker
SASY.PA
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Zain Ebrahim - JPMorgan Chase & Co, Research Division - Analyst : Zain Ebrahim, JPMorgan. So 2 for me, please. The first was just on PCV21. So the Phase II data that you showed, again, on those 3 showed strong sero response data versus registration hurdle on I think every strain except for maybe strain 6B. So I just wanted to understand how important that strain is for overall efficacy you think against invasive pneumococcal disease. And maybe bigger picture, how important do you think more functional endpoints in terms of efficacy against IPD or hospitalization would be needed for your PCV programs to drive approval, but also uptake ultimately? And then my second question, if I may, just going back to the first session. It's very clear that Fluzone High-Dose is the bar. Just wondering if you could provide us with an update on your expectations for Fluzone High-Dose this year.

Table Of Contents

Sanofi SA Q3 2023 Earnings Call Transcript – 2023-10-27 – US$ 54.00 – Edited Transcript of SASY.PA earnings conference call or presentation 27-Oct-23 12:30pm GMT

Sanofi SA at Bank of America Merrill Lynch Global Healthcare Conference Transcript – 2023-09-13 – US$ 54.00 – Edited Transcript of SASY.PA presentation 13-Sep-23 9:50am GMT

Sanofi SA at Morgan Stanley Global Healthcare Conference Transcript – 2023-09-12 – US$ 54.00 – Edited Transcript of SASY.PA presentation 12-Sep-23 2:10pm GMT

Sanofi SA at Citi BioPharma Conference Transcript – 2023-09-06 – US$ 54.00 – Edited Transcript of SASY.PA presentation 6-Sep-23 5:50pm GMT

Sanofi SA Q2 2023 Earnings Call Transcript – 2023-07-28 – US$ 54.00 – Edited Transcript of SASY.PA earnings conference call or presentation 28-Jul-23 12:30pm GMT

Sanofi SA at Goldman Sachs Healthcare Conference Transcript – 2023-06-14 – US$ 54.00 – Edited Transcript of SASY.PA presentation 14-Jun-23 5:00pm GMT

Sanofi SA Annual Shareholders Meeting Transcript – 2023-05-25 – US$ 54.00 – Edited Transcript of SASY.PA shareholder or annual meeting 25-May-23 12:30pm GMT

Sanofi SA ATS Investor Call Transcript – 2023-05-22 – US$ 54.00 – Edited Transcript of SASY.PA corporate analyst meeting</ 22-May-23 4:00pm GMT

Sanofi SA Q1 2023 Earnings Call Transcript – 2023-04-27 – US$ 54.00 – Edited Transcript of SASY.PA earnings conference call or presentation 27-Apr-23 12:30pm GMT

Sanofi SA Q4 2022 Earnings Call Transcript – 2023-02-03 – US$ 54.00 – Edited Transcript of SASY.PA earnings conference call or presentation 3-Feb-23 1:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Sanofi SA Vaccines Investor Event Transcript" Jun 29, 2023. Alacra Store. May 21, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Sanofi-SA-Vaccines-Investor-Event-T15603572>
  
APA:
Thomson StreetEvents. (2023). Sanofi SA Vaccines Investor Event Transcript Jun 29, 2023. New York, NY: Alacra Store. Retrieved May 21, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Sanofi-SA-Vaccines-Investor-Event-T15603572>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.